-
Pre-Open Stock Movers 02/21: (BXRX) (CRC) (DBX) Higher (TRUE) (BXC) (EYPT) Lower (more...)
-
Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
-
Agile Therapeutics (AGRX) to Offer Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
-
Agile Therapeutics (AGRX) PT Raised to $8 at RBC Capital After Twirla Approval
-
Agile Therapeutics (AGRX) PT Raised to $5 at RBC Capital on Surprise Twirla Recommendation
-
Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
-
Agile Therapeutics to Present at the 2019 RBC Capital Markets Global Healthcare Conference
-
Agile Therapeutics (AGRX) PT Lowered to $3 at RBC Capital
-
Agile Therapeutics (AGRX) PT Raised to $10 at RBC Capital on 'Meeting with Management, Nearing PDUFA'
-
Agile Therapeutics (AGRX): Analyst Day Preview - RBC
-
Agile Therapeutics (AGRX) Prices 5.33M Common Stock Offering at $3.75/Share
-
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Plans Offering of Common Stock
-
Agile Therapeutics Announces Proposed Offering of Common Stock
-
Agile Therapeutics to Present at the RBC Capital Markets 2017 Global Healthcare Conference
-
Agile Therapeutics (AGRX) Has Upside Remaining - RBC Capital
-
Agile Therapeutics (AGRX): Near Cash After Weak Phase III Data - RBC
-
Agile Therapeutics to Present at the 2016 RBC Capital Markets’ Global Healthcare Conference
-
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
-
RBC Capital Raises Price target on Agile Therapeutics (AGRX) Ahead of Phase III Data Read
-
Agile Therapeutics (AGRX) Prices 5.5M Common Stock Offering at $6.35/Share
-
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Plans $30M Common Stock Offering
-
Agile Therapeutics Announces Proposed Offering of Common Stock
-
Agile Therapeutics Announces Participation at Upcoming Investor Conferences
-
Agile Therapeutics (AGRX) IPO Opens 8% Lower
-
Agile Therapeutics (AGRX) Prices IPO at $6

